Quiflapon
|
|
Quiflapon Eigenschaften
- Siedepunkt:
- 751.3±60.0 °C(Predicted)
- Dichte
- 1.21±0.1 g/cm3(Predicted)
- L?slichkeit
- Soluble in DMSO
- Aggregatzustand
- Powder
- pka
- 4.70±0.10(Predicted)
- Farbe
- White to off-white
Sicherheit
Quiflapon Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
Anti-asthmatic; suppressant (inflammatory bowel disease).Quiflapon Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Quiflapon Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 85)Lieferanten
| Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
|---|---|---|---|---|---|
| TargetMol Chemicals Inc. | +1-781-999-5354; +17819995354 |
marketing@targetmol.com | United States | 32466 | 58 |
| HANGZHOU CLAP TECHNOLOGY CO.,LTD | 86-571-88216897,88216896 13588875226 |
sales@hzclap.com | CHINA | 6312 | 58 |
| Zhejiang J&C Biological Technology Co.,Limited | +1-2135480471 +1-2135480471; |
sales@sarms4muscle.com | China | 10457 | 58 |
| InvivoChem | +1-708-310-1919 +1-13798911105 |
sales@invivochem.cn | United States | 6391 | 58 |
| Nantong HI-FUTURE Biology Co., Ltd. | +undefined18051384581 |
sales@chemhifuture.com | China | 3135 | 58 |
| Aladdin Scientific | |
tp@aladdinsci.com | United States | 57505 | 58 |
| Chembest Research Laboratories Limited | 021-20908456 |
sales@BioChemBest.com | China | 6002 | 61 |
| BOC Sciences | 1-631-485-4226; 16314854226 |
info@bocsci.com | United States | 9920 | 65 |
| Nanjing JinruiJiuAn Biotechnology Co., Ltd. | 025-58196018 800028039 |
sales@fartop.net | China | 2229 | 55 |
| Haoyuan Chemexpress Co., Ltd. | 021-58950125 |
info@chemexpress.com | China | 7552 | 61 |
136668-42-3()Verwandte Suche:
- Quiflapon
- MK 0591
- 3-(3-(tert-butylthio)-1-(4-chlorobenzyl)-5-(quinolin-2-ylMethoxy)-1H-indol-2-yl)-2,2-diMethylpropanoic acid
- 1H-Indole-2-propanoic acid, 1-[(4-chlorophenyl)Methyl]-3-[(1,1-diMethylethyl)thio]-α,α-diMethyl-5-(2-quinolinylMethoxy)-
- MK 591(Quiflapon)
- 1-[(4-Chlorophenyl)methyl]-3-[(1,1-dimethylethyl)thio]-alpha,alpha-dimethyl-5-(2-quinolinylmethoxy)-1H-indole-2-propanoic acid
- MK-0591 (Quiflapon)
- 3-(3-(tert-Butylthio)-1-(4-chlorobenzyl)-5-(quinolin-2-ylmethoxy)-1H-indol-2-yl)-2,2-dimethylp
- QUIFLAPON; MK0591; MK 0591
- L-686708
- QUIFLAPON;MK-591;L-686708
- 3-[3-tert-butylsulfanyl-1-[(4-chlorophenyl)methyl]-5-(quinolin-2-ylmethoxy)indol-2-yl]-2,2-dimethylpropanoicaci
- MK591,FLAP,inhibit,5-LO activating protein,Quiflapon,MK 591,Inhibitor,Apoptosis
- Quiflapon, 10 mM in DMSO
- 136668-42-3
- C34H35ClN2O3S




